| 02.05 04:04 | dpa-AFX: Astellas, Poseida Collaborate To Develop Novel Allogeneic Cell Therapies In Oncology |
| 26.04 09:58 | MÄRKTE ASIEN/Freundlich - Yen lotet neue Tiefs aus |
| 25.04 12:51 | dpa-AFX: Astellas Pharma Annual Net Plunges, But Revenue Climbs; Expects 2024 Result To Improve |
| 25.04 11:13 | dpa-AFX: *ASTELLAS PHARMA FY REVENUE UP 5.6% TO 1.60 TRLN YEN |
| 24.04 02:57 | dpa-AFX: European Commission Approves Astellas' Xtandi For Recurrent Early Prostate Cancer Treatment |
| 24.04 02:29 | dpa-AFX: *EUROPEAN COMMISSION APPROVES ASTELLAS' XTANDI FOR RECURRENT EARLY PROSTATE CANCER TREATMENT EXPANSION |
| 22.04 11:12 | dpa-AFX: Takeda, Astellas, Sumitomo Mitsui Banking To Form JV For Incubation Of Early Drug Discovery Programs |
| 22.04 10:13 | dpa-AFX: *TAKEDA, ASTELLAS AND SUMITOMO MITSUI BANKING ANNOUNCE MASTER AGREEMENT TO ESTABLISH JOINT VENTURE COMPANY |
| 15.04 09:23 | MÄRKTE ASIEN/Börsen stecken Eskalation im Nahen Osten gut weg |
| 28.03 17:07 | dpa-AFX: Astellas & Pfizer's SBLA For Enfortumab Vedotin With Keytruda Gets Approval In China |
| 28.03 16:02 | dpa-AFX: *CHINA ACCEPTS ASTELLAS AND PFIZER'S SBLA FOR ENFORTUMAB VEDOTIN WITH KEYTRUDA FOR TREATMENT OF ADVANCED BLADDER CANCER |
| 26.03 13:47 | dpa-AFX: Astellas' Vyloy Approved In Japan For Gastric Cancer |
| 26.03 13:03 | dpa-AFX: *ASTELLAS' VYLOY APPROVED IN JAPAN FOR GASTRIC CANCER TREATMENT |
| 22.03 13:39 | dpa-AFX: Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting |
| 22.03 13:01 | dpa-AFX: *ASTELLAS GETS POSITIVE CHMP OPINION FOR XTANDI IN ADDL RECURRENT EARLY PROSTATE CANCER TREATMENT SETTING |
| 11.03 15:23 | dpa-AFX: Astellas Receives FDA Orphan Drug, Pediatric Exclusivities For Cresemba |
| 11.03 14:06 | dpa-AFX: *ASTELLAS PHARMA RECEIVES FDA EXCLUSIVITIES FOR CRESEMBA IN PEDIATRIC PATIENTS |
| 04.03 01:33 | dpa-AFX: *ASTELLAS INITIATES PHASE 3 STUDIES OF FEZOLINETANT FOR VMS ASSOCIATED WITH MENOPAUSE IN JAPAN |
| 31.01 03:26 | dpa-AFX: Astellas Submits SNDA In Japan For PADCEV-KEYTRUDA For Advanced Bladder Cancer Treatment |
| 31.01 01:18 | dpa-AFX: Astellas Pharma Announces Collaboration With Mass General Brigham |
|
|
